Park, Y. H., Kim, T. Y., Im, Y., Lee, K., Park, I. H., Sohn, J., . . . Jung, K. H. (2017). Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results. Cancer Res Treat.
Citación estilo ChicagoPark, Yeon Hee, et al. "Feasibility and Efficacy of Eribulin Mesilate in Korean Patients With Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results." Cancer Res Treat 2017.
Cita MLAPark, Yeon Hee, et al. "Feasibility and Efficacy of Eribulin Mesilate in Korean Patients With Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results." Cancer Res Treat 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.